Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gabriel Steg

Showing results (71-80 of 242) with videos related to

Pageof 25
Sort By:
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|May 1, 2010
Cardiovascular risk profiles and outcomes of Chinese living inside and outside ChinaJohn F Chiu, Alan D Bell, Robert J Herman, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
One-year costs in patients with a history of or at risk for atherothrombosis in the United StatesElizabeth M Mahoney, Kaijun Wang, David J Cohen, et al.
Heart (British Cardiac Society)|November 16, 2010
Quantitative troponin and death, cardiogenic shock, cardiac arrest and new heart failure in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS): insights from the Global Registry of Acute Coronary EventsSanjit S Jolly, Heather Shenkman, David Brieger, et al.
Archives of Internal Medicine|November 25, 2010
Metformin use and mortality among patients with diabetes and atherothrombosisRonan Roussel, Florence Travert, Blandine Pasquet, et al.
Thrombosis and Haemostasis|August 28, 2007
Prothrombotic markers and early spontaneous recanalization in ST-segment elevation myocardial infarctionMarie-Geneviève Huisse, Emilie Lanoy, Didier Tcheche, et al.
Lancet (London, England)|August 31, 2010
Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trialLars Wallentin, Stefan James, Robert F Storey, et al.
Circulation. Genomic and Precision Medicine|May 11, 2022
Pharmacogenomic Study of Statin-Associated Muscle Symptoms in the ODYSSEY OUTCOMES TrialWilliam A Murphy, Nan Lin, Amy Damask, et al.
Journal of the American Heart Association|December 30, 2022
Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary InterventionGuillaume Marquis-Gravel, Laurie-Anne Boivin-Proulx, Zhen Huang, et al.
Atherosclerosis|December 5, 2008
Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) RegistryPatrice P Cacoub, Maria Teresa B Abola, Iris Baumgartner, et al.
The Canadian Journal of Cardiology|November 25, 2011
The association between prior use of aspirin and/or warfarin and the in-hospital management and outcomes in patients presenting with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)Hani Amad, Andrew T Yan, Raymond T Yan, et al.
Pageof 25

Showing results (71-80 of 242) with videos related to

Sort By:
Pageof 25
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|May 1, 2010
Cardiovascular risk profiles and outcomes of Chinese living inside and outside ChinaJohn F Chiu, Alan D Bell, Robert J Herman, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
One-year costs in patients with a history of or at risk for atherothrombosis in the United StatesElizabeth M Mahoney, Kaijun Wang, David J Cohen, et al.
Heart (British Cardiac Society)|November 16, 2010
Quantitative troponin and death, cardiogenic shock, cardiac arrest and new heart failure in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS): insights from the Global Registry of Acute Coronary EventsSanjit S Jolly, Heather Shenkman, David Brieger, et al.
Archives of Internal Medicine|November 25, 2010
Metformin use and mortality among patients with diabetes and atherothrombosisRonan Roussel, Florence Travert, Blandine Pasquet, et al.
Thrombosis and Haemostasis|August 28, 2007
Prothrombotic markers and early spontaneous recanalization in ST-segment elevation myocardial infarctionMarie-Geneviève Huisse, Emilie Lanoy, Didier Tcheche, et al.
Lancet (London, England)|August 31, 2010
Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trialLars Wallentin, Stefan James, Robert F Storey, et al.
Circulation. Genomic and Precision Medicine|May 11, 2022
Pharmacogenomic Study of Statin-Associated Muscle Symptoms in the ODYSSEY OUTCOMES TrialWilliam A Murphy, Nan Lin, Amy Damask, et al.
Journal of the American Heart Association|December 30, 2022
Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary InterventionGuillaume Marquis-Gravel, Laurie-Anne Boivin-Proulx, Zhen Huang, et al.
Atherosclerosis|December 5, 2008
Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) RegistryPatrice P Cacoub, Maria Teresa B Abola, Iris Baumgartner, et al.
The Canadian Journal of Cardiology|November 25, 2011
The association between prior use of aspirin and/or warfarin and the in-hospital management and outcomes in patients presenting with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)Hani Amad, Andrew T Yan, Raymond T Yan, et al.
Pageof 25